David W. Carley

Direttore Tecnico/Scientifico/R&S presso Pier Pharmaceuticals, Inc.

Health Technology

Consumer Services

Finance

Posizioni attive di David W. Carley

Società	Posizione	Inizio	Fine
Pier Pharmaceuticals, Inc. Pier Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Pier Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company which develops a pharmacologic treatment for obstructive sleep apnea (OSA). It develops Dronabinol a synthetic derivative of the naturally occurring substance in the cannabis plant, namely delta-9-tetrahydrocannabinol, otherwise known as delta-9 THC. The company was founded in 2007 and is headquartered in Louiseville, CO.	Direttore/Membro del Consiglio	29/06/2011	-
	Direttore Tecnico/Scientifico/R&S	29/06/2011	-
University of Illinois	Corporate Officer/Principal	29/06/2011	-

Società	Posizione	Inizio	Fine
RESPIRERX PHARMACEUTICALS INC.	Direttore/Membro del Consiglio	10/08/2012	-

Massachusetts Institute of Technology	Graduate Degree
Harvard University	Doctorate Degree

Distribuzione geografica

Stati Uniti

Posizioni

Settori

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
RESPIRERX PHARMACEUTICALS INC.	Health Technology

Aziende private	1
Pier Pharmaceuticals, Inc. Pier Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Pier Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company which develops a pharmacologic treatment for obstructive sleep apnea (OSA). It develops Dronabinol a synthetic derivative of the naturally occurring substance in the cannabis plant, namely delta-9-tetrahydrocannabinol, otherwise known as delta-9 THC. The company was founded in 2007 and is headquartered in Louiseville, CO.	Health Technology

Aziende private

Health Technology